Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
SQI Diagnostics Inc Explores Strategic Alternatives-Reuters
Reuters reported that SQI Diagnostics Inc is exploring strategic alternatives, including a sale or merger. The Company has appointed a committee that will review the interests it has received. SQI intends to actively explore these and other alternatives, including strategic alliances. Investment bank Cantor Fitzgerald is advising the Company.
Latest Developments for Sqi Diagnostics Inc
- SQI Diagnostics Inc. Announces Private Placement Of Up To CAD9 Million
- SQI Diagnostics Inc. Announces Realignment of Business and Reductions in Operating Expenses
- SQI Diagnostics Inc. Announces Amendment to Acquisition Agreement for Proposed Acquisition of Scienion AG
- SQI Diagnostics Inc. To Acquire Scienion AG
- Share this
- Link this
- Digg this
Follow Reuters